P2Y11 receptor expression by human lymphocytes: Evidence for two cAMP-linked purinoceptors

European Journal of Pharmacology

Volumn 426, Issue 3, 2001, Pages 157-163

  Conigrave, Arthur D ^a   Fernando, Kekulu C ^a   Gu, Ben ^a   Tasevski, Vitomir ^b   Zhang, Weiyi ^a   Luttrell, Brian M ^b   Wiley, James S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Adenosine A2 receptor; ATP; B lymphocytes; cAMP; Chronic lymphocytic leukemia; Human; P2Y11 receptor

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE 5' THIOMONOPHOSPHATE; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A2B RECEPTOR AGONIST; ADENOSINE DEAMINASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CYCLIC AMP; MESSENGER RNA; NUCLEOTIDE; PURINE P2Y RECEPTOR; PURINE P2Y2 RECEPTOR AGONIST; PURINE RECEPTOR; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL MATURATION; CHRONIC LYMPHATIC LEUKEMIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTES; RECEPTORS, PURINERGIC P2; RNA, MESSENGER;

EID: 0035979725     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01222-5     Document Type: Article

References (33)

1. Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells
2. P2 purinoceptors: Localization, function and transduction mechanism
3. Extracellular ATP-stimulated increase of cytosolic cAMP in HL60 cells
4. Cloning of a human P2Y receptor coupled to phospholipase C and adenylyl cyclase
5. 11 receptor
6. Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells
7. Enhancement of endothelial cAMP accumulation by adenine nucleotides: Role of methylxanthine-sensitive sites
8. Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells
9. Invited review-signal transduction via P2 purinergic receptors for extracellular ATP and other nucleotides
10. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role
11. Phosphodiesterase profile of human B-lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation
12. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes
13. B cell differentiation factor-induced B cell maturation: Regulation via reduction in cAMP
14. Adenosine receptor ligands: Differences with acute versus chronic treatment
15. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells
16. Distribution of P2Y receptor subtypes on haematopoietic cells
17. Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia
18. 2A receptor monoclonal antibodies
19. Reaction coupling of chelation and antigen binding in the calcium ion-dependent antibody binding of cyclic AMP
20. Involvement of cAMP in CD3 T cell receptor complex- and CD2-mediated apoptosis of human thymocytes
21. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells
22. Theophylline-induced B-CLL apoptosis is partly dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production
23. Effects of P1 and P2 receptor antagonists on beta, gamma-methylene ATP- and CGS21680-induced cyclic AMP formation in NG108-15 cells
24. P2 purinergic agonists enhance cAMP production in Madin-Darby canine kidney epithelial cells via an autocrine/paracrine mechanism
25. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA
26. 5′-Nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia
27. Human lymphocytes: 5′-Nucleotidase-positive and -negative subpopulations
28. Cyclic adenosine 3′,5′-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation
29. Pharmacological characterization of the P2Y11 receptor in stably transfected haematological cell lines
30. Extracellular ATP couples to cAMP generation and granulocytic differentiation in human NB4 promyelocytic leukaemia cells
31. Extracellular adenosine triphosphate increases cation permeability of chronic leukemic lymphocytes
32. 7 channel
33. Adenosine inhibition of lymphocyte-mediated cytolysis: Possible role of cyclic adenosine monophosphate